首页 | 本学科首页   官方微博 | 高级检索  
     


Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm,phase 1 trials
Authors:Wenfeng Fang  Yunpeng Yang  Yuxiang Ma  Shaodong Hong  Lizhu Lin  Xiaohui He  Jianping Xiong  Ping Li  Hongyun Zhao  Yan Huang  Yang Zhang  Likun Chen  Ningning Zhou  Yuanyuan Zhao  Xue Hou  Qing Yang  Li Zhang
Affiliation:1. Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China;2. Department of Clinical Research, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China;3. The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, China;4. Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China;5. The First Affiliated Hospital of Nanchang University, Nanchang, China;6. West China Hospital, Sichuan University, Chengdu, China;7. Jiangsu Hengrui Medicine Co. Ltd, Lianyungang, China
Abstract:
Keywords:Correspondence to: Prof Li Zhang   Department of Medical Oncology   Sun Yat-sen University Cancer Center   State Key Laboratory of Oncology in South China   Collaborative Innovation Center for Cancer Medicine   Guangzhou 510060   China
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号